Facebook Users

Will GIMU go up?

GIMU Global Immune Technologies Inc. featured news, full reports, and detailed charts

Global Immune Technologies Inc. (GIMU/GIMU.PK) Wrap Up:

Global Immune Technologies, Inc. does not have significant operations. The company intends to seek various business opportunities. Previously, it was engaged in the development and maintenance of various Internet-based games and contests. The company is based in Sydney Mines, Canada.

Global Immune Technologies Inc. (GIMU:OTC)

Market Cap
325.5K
Total Revenue
--
EBITDA
--
DILUTED EPS TTM
-0.01
P/E
--
P/S
--
Return On Asset
--
Return On Equity
20.18
K = Thousands  M = Millions  B = Billions

GIMU Top Compensated Officers

Mr. Donald L. Perks
Chief Executive Officer, President, Chief Fin...
Age: 57
Total Annual Compensation: $27.0K

Executives, Board Directors

Compensation as of Fiscal Year 2008.

Key developments for Global Immune Technologies Inc. (GIMU)

Global Immune Technologies Inc. Announces Change of Address

Global Immune Technologies Inc. announced that it has moved its principal executive offices from 45 Brown Street, Sydney Mines, Nova Scotia, Canada to Avenida Jaime III, 25 1-B, 07012 Palma de Mallorca, Spain as of May 12, 2009.

Global Immune Technologies Inc. Auditor Raises 'Going Concern' Doubt

Global Immune Technologies Inc. filed its 10-K on June 30, 2008 for the period ending March 31, 2008. In this report its auditor, Jorgensen & Co., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Global Immune Technologies Inc. announced delayed 10-Q filing

On 02/14/2008, Global Immune Technologies Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

otc, otcbb, pinksheet, GIMU, ob Global Immune Technologies Inc.

GIMU Competitors

Company Last Change
No competitor information is available for GIMU.
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation GIMU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

GIMU

GIMU transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent News About Global Immune Technologies Inc.

More news for GIMU

GLOBAL IMMUNE TECHNOLOGIES INC. Files SEC form 8-K, Other Events

Show all filings for GLOBAL IMMUNE TECHNOLOGIES INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for GLOBAL IMMUNE TECHNOLOGIES INC. 12-May-2009Other Events Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, n...
Click here to read the whole Article (external link)

GLOBAL IMMUNE TECHNOLOGIES INC. Financials

PERIOD ENDING31-Dec-0830-Sep-0830-Jun-0831-Mar-08Total Revenue -   -   -   -  Cost of Revenue -   -   -   -  Gross Profit -   -   -   -  Operating ExpensesResearch Development -   -   -   -  Selling General and Administrative18  8  18  82  Non Recurring -   -   -   -  Others -   -   -   -  Total Operating Expenses -   -   -   -  Operating Income or Loss(18)(8)(18)(82)Income from Continuing OperationsTotal Other Income/Expenses Net -   -   -   -  Earnings Before Interest And Taxes(18)(8)(18)(82)Interest Expense -   -   -   -  Income Before Tax(18)(8)(18)(82)Income Tax Expense -   -   -   -  Minority Interest -   -   -   -  Net Income From Continuing Ops(18)(8)(18)(82)Non-recurring EventsDiscontinued Operations -   -   -   -  Extraordinary Items -   -   -   -  ...
Click here to read the whole Article (external link)

GLOBAL IMMUNE TECHNOLOGIES INC. Files SEC form 10-Q, Quarterly Report

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations FORWARD-LOOKING STATEMENT NOTICE: This quarterly report on Form 10-Q and our future filings with the Securities and Exchange Commission contain many forward-looking statements, which involve risks and uncertainties. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, statements such as our plans, objective, expectations and intentions. You can identify these statements by our use of words such as "may," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," or other similar words or phrases. Some of these statements include discussions regarding our future business strategy and our ability to generate revenue, income, and cash flow. Table of Contents These statements are intended to identify forward-looking statements within the meaning of the various securities acts. We wish to caution the reader that all forward-looking statements contained in this Form 10-Q are only estimates and predictions. Our actual results could differ materially from those anticipated as a result of risk facing us or actual events differing from the assumptions underlying such forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements contained in this Quarterly Report on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements. We undertake no obligation to update any of these factors or to publicly announce any change to our forward-looking statements made herein, whether as a result of new information, future events, changes in expectations or otherwise. Overview (a) Our Corporate History. The Company was in...
Click here to read the whole Article (external link)

GLOBAL IMMUNE TECHNOLOGIES INC. Files SEC form 10-Q, Quarterly Report

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations FORWARD-LOOKING STATEMENT NOTICE: This quarterly report on Form 10-Q and our future filings with the Securities and Exchange Commission contain many forward-looking statements, which involve risks and uncertainties. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, statements such as our plans, objective, expectations and intentions. You can identify these statements by our use of words such as "may," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," or other similar words or phrases. Some of these statements include discussions regarding our future business strategy and our ability to generate revenue, income, and cash flow. Table of Contents These statements are intended to identify forward-looking statements within the meaning of the various securities acts. We wish to caution the reader that all forward-looking statements contained in this Form 10-Q are only estimates and predictions. Our actual results could differ materially from those anticipated as a result of risk facing us or actual events differing from the assumptions underlying such forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements contained in this Quarterly Report on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements. We undertake no obligation to update any of these factors or to publicly announce any change to our forward-looking statements made herein, whether as a result of new information, future events, changes in expectations or otherwise. Overview (a) Our Corporate History. The Company was in...
Click here to read the whole Article (external link)

Would you like to leave a comment about Global Immune Technologies Inc. GIMU/GIMU.PK

Besides Global Immune Technologies Inc. there is more great information available at Realpennies.com